Clobazam Oral Suspension 2 — Class II drug recall D-0376-2022
Terminated recall by VistaPharm, Inc., reported 2022-01-26, distributed nationwide. Failed Stability Specifications
| Recall number | D-0376-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | VistaPharm, Inc., Largo, FL, United States |
| Recall initiated | 2022-01-07 |
| Classified | 2022-01-18 |
| Reported by FDA | 2022-01-26 |
| Terminated | 2024-12-13 |
| Distributed | Nationwide (US) |
| Quantity | 18,456 bottles |
| Reason classes | specification failure |
| NDC | 66689-0058-04 |
| Lot numbers | 678900, 680600, 680800, 681000, 682000, 682400, 683200, 685200, 728900, 733100, 738600, 740600, 741600, 749800, 750900, 752400, 775700 |
| Expiration dates | 2022-05-30, 2022-05-31, 2022-06-30, 2022-12-31, 2023-01-31, 2023-02-28, 2023-03-31, 2023-06-30 |
Product
Clobazam Oral Suspension 2.5 mg/mL, 120 mL bottles, Rx only, Manufactured by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-058-04
Reason for recall
Failed Stability Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0376-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.